Literature DB >> 8176268

Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.

R Malhotra1, N Ratner.   

Abstract

Pigmentation defects are common in the inherited disease type 1 neurofibromatosis (NF1), predicting a role for the NF1 gene product, neurofibromin, in the skin. We used immunohistochemistry to determine the distribution of neurofibromin in normal developing and adult rat skin, normal neonatal and adult human skin, and skin from patients affected with NF1. The distribution of NF1 mRNA in the epidermis was also analyzed by in situ hybridization. NF1 mRNA and neurofibromin are highly enriched in the keratinocytes in the stratum spinosum of the epidermis in the embryonic, but not adult, rat and in both neonatal and adult humans. Immunoelectron microscopic analysis confirmed that neurofibromin is associated with the keratinocyte plasma membrane, particularly adjacent to desmosomes. Neurofibromin is also detectable in human melanocytes. Analysis of skin from NF1 patients showed normal neurofibromin expression in nine of ten hyperpigmented cafe-au-lait macules and in adjacent unaffected skin. We conclude that 1) neurofibromin expression in the perinatal rat closely parallels expression in the human; 2) reduction in detectable neurofibromin cannot be used to distinguish NF1 and normal human skin; and 3) neurofibromin might function in keratinocytes, as well as melanocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176268     DOI: 10.1111/1523-1747.ep12379925

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 2.  Emerging pharmacotherapies for neurodevelopmental disorders.

Authors:  Daniel Z Wetmore; Craig C Garner
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

3.  The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.

Authors:  R P Atit; M J Crowe; D G Greenhalgh; R J Wenstrup; N Ratner
Journal:  J Invest Dermatol       Date:  1999-06       Impact factor: 8.551

4.  The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.

Authors:  R P Atit; K Mitchell; L Nguyen; D Warshawsky; N Ratner
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

Review 5.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

6.  Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro.

Authors:  Ralf Kemkemer; Stephanie Schrank; Walther Vogel; Hans Gruler; Dieter Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

7.  NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.

Authors:  Jean-Philippe Brosseau; Chung-Ping Liao; Yong Wang; Vijay Ramani; Travis Vandergriff; Michelle Lee; Amisha Patel; Kiyoshi Ariizumi; Lu Q Le
Journal:  Nat Commun       Date:  2018-11-27       Impact factor: 14.919

8.  Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.

Authors:  Maria Malminen; Sirkku Peltonen; Jussi Koivunen; Juha Peltonen
Journal:  BMC Dermatol       Date:  2002-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.